Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pharmacogenetics and genomics

Showing results (1-10 of 1,528) with videos related to

Pageof 153
Sort By:
Pharmacogenetics and Genomics|October 5, 2020
Patient insights on features of an effective pharmacogenomics patient portalTien M Truong, Elizabeth Lipschultz, Emily Schierer, et al.
Pharmacogenetics and Genomics|July 19, 2022
Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitisQinghong Dai, Xuyang Xia, Chenjia He, et al.
Pharmacogenetics and Genomics|July 1, 2010
Effects of the CYP3A5*3 variant on cyclosporine exposure and acute rejection rate in renal transplant patients: a meta-analysisHui-Lin Tang, Lu-Lin Ma, Hong-Guang Xie, et al.
Pharmacogenetics and Genomics|October 27, 2010
Are genetic variants of COMT associated with addiction?Anne Emilia Tammimäki, Pekka T Männistö
Pharmacogenetics and Genomics|July 27, 2010
The metabotropic glutamate receptor subtype 5 mediates sensitivity to the sedative properties of ethanolChris Downing, Michael J Marks, Colin Larson, et al.
Pharmacogenetics and Genomics|August 4, 2010
Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetilOlivier Gensburger, Ron H N Van Schaik, Nicolas Picard, et al.
Pharmacogenetics and Genomics|August 26, 2010
PharmGKB summary: dopamine receptor D2Huaiyu Mi, Paul D Thomas, Huijun Z Ring, et al.
Pharmacogenetics and Genomics|November 11, 2010
Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genesMartina Teichert, Mark Eijgelsheim, Andrė G Uitterlinden, et al.
Pharmacogenetics and Genomics|February 1, 2011
Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificityUte I Schwarz, Henriette E Meyer zu Schwabedissen, Rommel G Tirona, et al.
Pharmacogenetics and Genomics|February 1, 2011
The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humansJunko Imanaga, Tsutomu Kotegawa, Hiromitsu Imai, et al.
Pageof 153

Showing results (1-10 of 1,528) with videos related to

Sort By:
Pageof 153
Pharmacogenetics and Genomics|October 5, 2020
Patient insights on features of an effective pharmacogenomics patient portalTien M Truong, Elizabeth Lipschultz, Emily Schierer, et al.
Pharmacogenetics and Genomics|July 19, 2022
Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitisQinghong Dai, Xuyang Xia, Chenjia He, et al.
Pharmacogenetics and Genomics|July 1, 2010
Effects of the CYP3A5*3 variant on cyclosporine exposure and acute rejection rate in renal transplant patients: a meta-analysisHui-Lin Tang, Lu-Lin Ma, Hong-Guang Xie, et al.
Pharmacogenetics and Genomics|October 27, 2010
Are genetic variants of COMT associated with addiction?Anne Emilia Tammimäki, Pekka T Männistö
Pharmacogenetics and Genomics|July 27, 2010
The metabotropic glutamate receptor subtype 5 mediates sensitivity to the sedative properties of ethanolChris Downing, Michael J Marks, Colin Larson, et al.
Pharmacogenetics and Genomics|August 4, 2010
Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetilOlivier Gensburger, Ron H N Van Schaik, Nicolas Picard, et al.
Pharmacogenetics and Genomics|August 26, 2010
PharmGKB summary: dopamine receptor D2Huaiyu Mi, Paul D Thomas, Huijun Z Ring, et al.
Pharmacogenetics and Genomics|November 11, 2010
Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genesMartina Teichert, Mark Eijgelsheim, Andrė G Uitterlinden, et al.
Pharmacogenetics and Genomics|February 1, 2011
Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificityUte I Schwarz, Henriette E Meyer zu Schwabedissen, Rommel G Tirona, et al.
Pharmacogenetics and Genomics|February 1, 2011
The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humansJunko Imanaga, Tsutomu Kotegawa, Hiromitsu Imai, et al.
Pageof 153